NICE moves to standardize ablative therapies for treating Barrett's esophagus

The National Institute for Health and Clinical Excellence (NICE) has issued new guidelines recommending that clinicians consider offering endoscopic resection (ER) of high-grade dysplasia and intramucosal cancer as an alternative to removal of the affected part of the esophagus (esophagectomy) for the treatment of Barrett's esophagus. The guidelines specify laser ablation and photodynamic therapy (PDT) among other therapies—and suggest that ER should also be considered alone to treat localized lesions.

It is the first time that NICE has issued guidelines relating to the the use of ablative therapies for the treatment of Barrett's esophagus. Ablative therapies destroy the abnormal cells within the esophagus caused by this condition, without the need to remove an entire section of the esophagus. The condition is a direct consequence of long-term, chronic gastro-esophageal reflux disease (GERD). The cells that line the affected area of the esophagus become inflamed and if this happens over many years, these cells may start to change, becoming more like the cells that line the intestine. In some patients, these changes can lead to esophageal cancer.

In the UK, around 1% of the population are currently affected by Barrett's esophagus, placing a significant cost burden on the health service and the need to select the most cost-effective and clinically beneficial therapy. The lack of any previous advice on treatment options has led to widespread variation in treatments being offered. These new guidelines subsequently set out as a clinical pathway for the treatment of Barrett's esophagus in England and Wales. 

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

(SLIDESHOW) View the July/August 2013 issue

ONCOLOGY/CANCER TREATMENT: Study reveals potential of terahertz pulses to fight cancer

Terahertz (THz) photons don't have sufficient energy to break apart the bonds that bind DNA in a cell's nucleus.

OPTOACOUSTICS/OXIMETRY: Real-time photoacoustics beats pulse oximetry by measuring oxygenation in single cells

Red blood cells ferry oxygen to a body's cells and tissues by way of arteries, veins, and capillaries.

SPECTROSCOPY/ONCOLOGY/GYNECOLOGY: First-ever minimally invasive ovarian cancer screen is spectroscopy-based

Researchers at Northwestern University and NorthShore University HealthSystem have previously demonstrated the ability of partial-wave spectroscopy to detect subtle changes in cells that indicate c...

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS